Stryker

(SYK)

Financial Overview

Target Price $29.64
Market Cap $135.00B
P/E Ratio 30.64
Risk Rating Medium

About Stryker

Stryker Corporation, led by CEO Kevin Lobo, is a leading medical technology company specializing in surgical equipment, orthopedics, neurotechnology, and spine devices. The company serves hospitals and surgical centers globally. Under Lobo, Stryker has expanded through acquisitions and innovation in robotic surgery. It is a top performer in medical device reliability and patient outcomes. Stryker continues to drive advancements in surgical precision and recovery solutions.

Analyst Forecast

Stryker is benefiting from a recovery in elective procedures and a strong orthopedic pipeline, but valuation is demanding and hospital capital budgets remain stretched. Integration risk from recent acquisitions is non-trivial, and innovation in surgical robotics is facing stiff competition from peers like Intuitive Surgical. Solid fundamentals, but downside could emerge if procedure volumes stumble or pricing pressure intensifies.

Analysis by Luigi Wewege

Luigi Wewege

President at Caye International Bank

Luigi Wewege is President of the award-winning Caye International Bank. He is the author of The Digital Banking Revolution, now in its third edition, and of the article “Disruptions and Digital Banking Trends,” published in The Journal of Applied Finance & Banking. Luigi has also co-authored economic research examining the accuracy of credit bureau data, which was presented before the United States Congress. At Caye Bank, his research and strategic insights help guide billions in client portfolio decisions across international markets. Known for his disciplined diversification philosophy, he served as the conceptual architect behind this Portfolio Fit Calculator. He holds an Italian MBA specializing in International Business, and earned his BSBA with a triple major in Finance, International Business, and Management, graduating with Latin Honors from the University of Missouri–St. Louis.

18 years of experience

Should You Buy Stryker Stock?

This interactive tool helps you determine whether this stock fits into your investment strategy based on your portfolio size, risk tolerance, and allocation preferences.

What this calculator analyzes:

  • Risk compatibility between your profile and this stock
  • Appropriate allocation size for your portfolio
  • Diversification recommendations
  • P/E ratio context and valuation analysis

Example Analysis:

A 30.64 P/E ratio indicates this stock trades at a premium valuation. With a Medium risk rating, this stock may suit moderate risk tolerance.

$1K $10M
1% 100%

⚠️ This tool is for informational purposes only. It does not constitute financial advice. Investing involves risk, including loss of capital. Always consult a licensed financial advisor before making investment decisions.